A New Player in the Weight Loss Pill Game
Eli Lilly is making waves in the weight loss drug market with its new obesity pill, orforglipron. This pill is set to compete with Novo Nordisk's oral semaglutide, which has shown promising results. Both drugs work by mimicking a gut hormone called GLP-1 to help control appetite and blood sugar levels. Eli Lilly's pill is a small-molecule drug, which means it is abs...